LIQUIDIA

Pharmaceuticals for treatment of respiratory diseases, namely, pharmaceuticals in the form of capsules comprised of microparticles and nanoparticles composed of polymers, excipients, therapeutics, and biologics; Pharmaceuticals for treatment of respiratory diseases, namely, pharmaceuticals in the nature of microparticles and nanoparticles with prophylactic properties composed of polymers, excipients, therapeutics, and biologics;